Cancer Clinical Trials
We conduct cancer clinical trials to provide cutting edge technologies and treatments and advance research outcomes for patients. Our physician scientists and other providers treat over 4,000 new cancer cases each year and enroll patients on over 200 currently active cancer clinical trials. We have dedicated space for clinical research and the region’s only Translational Research Unit, designed just for patients participating in early phase (phase I/II) clinical trials. As our laboratory research leads to important new targets in the war on cancer, a dedicated unit to perform first in human cancer treatment trials makes these promising treatments available to patients sooner.
We are also proud to support clinical cancer research with partners throughout our community:
- Froedtert Hospital, Milwaukee
- Children's Hospital of Wisconsin
- Community Memorial Hospital, Menomonee Falls
- St. Joseph’s Hospital, West Bend
- Clement J. Zablocki VA Medical Center
Jim Thomas, MD, PhD, Medical Director of the MCWCC Clinical Trials Office, shares the latest on personalized cancer treatment in Managed Healthcare Executive.
The MCW Cancer Center is testing a new drug for advanced or metastatic triple-negative breast cancer, typically a more aggressive type of breast cancer with fewer good options for treatment.
For patients whose treatment for diffused large B cell lymphoma ended unsuccessfully this new clinical trial may present renewed possibilities for hope along with understanding medicines new frontier.
Clinical Trials Office
Medical College of Wisconsin
Cancer Center Clinical Trials Office (CTO)
9200 W. Wisconsin Ave.
Milwaukee, WI 53226
(414) 805-8900 | Fax: (414) 805-0596